TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31422216

Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg every 2 weeks
Number of subjects: 361

Group type: COMPARATOR
Intervention: Investigator's choice (IC) of single-agent chemotherapy (methotrexate, docetaxel, or cetuximab)
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 361
Study: 27977513

Group type: EXPERIMENTAL
Intervention: Moderate pressure massage applied to the shoulders and neck
Number of subjects: 17

Group type: COMPARATOR
Intervention: Quiet sitting
Number of subjects: 17
Study: 26041132

Group type: EXPERIMENTAL
Intervention: Interprofessional education (IPE) programme (11 hours)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group (usual discipline specific curriculum)
Number of subjects: 83
Study: 23517809

Group type: EXPERIMENTAL
Intervention: Bladder-rectum spacer balloon (BRSB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard gauze packing
Number of subjects: 40
Study: 21917518

Group type: EXPERIMENTAL
Intervention: Anthracycline-based treatment
Number of subjects: 3452

Group type: COMPARATOR
Intervention: Altered TOP2A cohort (deleted and amplified combined)
Number of subjects: 3452
Study: 18937013

Group type: EXPERIMENTAL
Intervention: Coronary risk profile every three months
Number of subjects: 2631

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2631
Study: 16913498

Group type: EXPERIMENTAL
Intervention: Dan Shao Tang (DST) and western medicine
Number of subjects: 72

Group type: COMPARATOR
Intervention: Western medicine
Number of subjects: 72
Study: 15496698

Group type: EXPERIMENTAL
Intervention: Corticosteroids treatment in head injury (intervention group where consent was waived)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corticosteroids treatment in head injury (control group where consent was required)
Number of subjects: 0
Study: 11273944

Group type: EXPERIMENTAL
Intervention: 0.05% bupivacaine/4 microg fentanyl
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.1% bupivacaine/fentanyl
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.05% ropivacaine/fentanyl
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.1% ropivacaine/fentanyl
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.05% or 0.1% solutions of bupivacaine/fentanyl and ropivacaine/fentanyl
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.05% solution
Number of subjects: 40
Study: 9563925

Group type: EXPERIMENTAL
Intervention: Interferon-alpha 2b and ursodeoxycholic acid
Number of subjects: 31

Group type: COMPARATOR
Intervention: Interferon-alpha 2b alone (monotherapy)
Number of subjects: 31
Study: 9316679

Group type: EXPERIMENTAL
Intervention: Piracetam
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 3592847

Group type: EXPERIMENTAL
Intervention: 400 mg oxpentifylline thrice daily for 12 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Matched placebo tablets for 12 weeks
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 400 mg oxpentifylline for MID patients (n = 4)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Matched placebo for MID patients (n = 7)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 400 mg oxpentifylline for PDD patients
Number of subjects: 25
Study: 30755718

Group type: EXPERIMENTAL
Intervention: NIPPV inflations associated with patient effort
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Spontaneous breaths without ventilator assistance
Number of subjects: 14

Group type: COMPARATOR
Intervention: Ventilator-only inflations
Number of subjects: 14
Study: 29293900

Group type: EXPERIMENTAL
Intervention: Forced Choice Recognition (FCR) ≤15
Number of subjects: 104

Group type: COMPARATOR
Intervention: Forced Choice Recognition (FCR) ≤14
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Patients who failed the FCR
Number of subjects: 104
Study: 26564446

Group type: EXPERIMENTAL
Intervention: Longitudinal changes in corneal curvature (CC)
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Correlation between axial length (AL) and corneal curvature (CC)
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Average axial length/corneal radius (AL/CR) ratio
Number of subjects: 469
Study: 24731620

Group type: EXPERIMENTAL
Intervention: Glucose
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 22257825

Group type: EXPERIMENTAL
Intervention: TMZ plus WBI (30 Gy in 10 fractions over 2 weeks with 200 mg TMZ on M/W/F and 300 mg TMZ on T/Th)
Number of subjects: 55

Group type: COMPARATOR
Intervention: WBI alone (30 Gy in 10 fractions over 2 weeks)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: TMZ plus WBI
Number of subjects: 55

Group type: COMPARATOR
Intervention: WBI alone
Number of subjects: 55
Study: 20680385

Group type: EXPERIMENTAL
Intervention: Ice water ingestion (250 ml)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Room temperature water ingestion (control)
Number of subjects: 53
Study: 17714551

Group type: EXPERIMENTAL
Intervention: Alutard SQ P. pratense 100,000 SQ-U
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Alutard SQ P. pratense 10,000 SQ-U
Number of subjects: 410

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 410
Study: 14709940

Group type: EXPERIMENTAL
Intervention: Nefazodone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 16
Study: 11137416

Group type: EXPERIMENTAL
Intervention: neostigmine + bupivacaine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ketamine + bupivacaine
Number of subjects: 30

Group type: COMPARATOR
Intervention: bupivacaine alone
Number of subjects: 30
Study: 9099400

Group type: EXPERIMENTAL
Intervention: Special Intervention (SI) - intensive smoking cessation program
Number of subjects: 12866

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 12866

Group type: EXPERIMENTAL
Intervention: Special Intervention (SI)
Number of subjects: 12866

Group type: EXPERIMENTAL
Intervention: Special Intervention (SI) and Usual Care (UC)
Number of subjects: 12866
Study: 8265878

Group type: EXPERIMENTAL
Intervention: Buspirone (20 mg daily for 14 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 3011023

Group type: EXPERIMENTAL
Intervention: Guar gum (6.6 g)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (no guar gum)
Number of subjects: 16
Study: 2890550

Group type: EXPERIMENTAL
Intervention: Olsalazine sodium 0.75 g
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Olsalazine sodium 1.5 g
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Olsalazine sodium 3 g
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Combined olsalazine group
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Sigmoidoscopic criteria
Number of subjects: 66
Study: 30537261

Group type: EXPERIMENTAL
Intervention: Troponin T (TnT) elevated to >18 ng/L and NT-proBNP in the highest tertile (9% of all patients)
Number of subjects: 1907

Group type: COMPARATOR
Intervention: Troponin T (TnT) <18 ng/L and NT-proBNP in the lowest tertile (16% of all patients)
Number of subjects: 1907
Study: 28535776

Group type: EXPERIMENTAL
Intervention: Omalizumab (anti-IgE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25592014

Group type: EXPERIMENTAL
Intervention: Vegan diet
Number of subjects: 63

Group type: COMPARATOR
Intervention: Omnivorous diet
Number of subjects: 63

Group type: COMPARATOR
Intervention: Semi-vegetarian diet
Number of subjects: 63

Group type: COMPARATOR
Intervention: Pesco-vegetarian diet
Number of subjects: 63
Study: 22458649

Group type: EXPERIMENTAL
Intervention: School-based intervention (4 days/week of exercise for 45 min/day and 1 day/week of nutritional counselling for 6 months)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Self-help control
Number of subjects: 221
Study: 21455612

Group type: EXPERIMENTAL
Intervention: PRT + fortified milk supplement
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Fortified milk supplement
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: PRT
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study: 17611123

Group type: EXPERIMENTAL
Intervention: Self-involvement through guided evaluative processing and explicit association with self
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selection (choice-based processing)
Number of subjects: 0
Study: 16426962

Group type: EXPERIMENTAL
Intervention: Micronutrient-fortified beverage
Number of subjects: 869

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 869
Study: 15330403

Group type: EXPERIMENTAL
Intervention: Psychosocial service utilization (therapy with a psychologist, self-help group, therapy with a social worker, therapy with another type of provider)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Presence of personality disorders
Number of subjects: 500

Group type: COMPARATOR
Intervention: Presence of alcohol/drug abuse disorders
Number of subjects: 500

Group type: COMPARATOR
Intervention: Presence of anxiety disorders
Number of subjects: 500

Group type: COMPARATOR
Intervention: Global functioning
Number of subjects: 500

Group type: COMPARATOR
Intervention: Marital status
Number of subjects: 500
Study: 11130743

Group type: EXPERIMENTAL
Intervention: Sildenafil 200 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 9228814

Group type: EXPERIMENTAL
Intervention: Ineraid cochlear implant with analog processing
Number of subjects: 49

Group type: COMPARATOR
Intervention: Nucleus cochlear implant with feature-extraction processing
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both Ineraid and Nucleus cochlear implants
Number of subjects: 49
Study: 8112068

Group type: EXPERIMENTAL
Intervention: Locobase (moisturizer) used for 2 weeks (period L)
Number of subjects: 111

Group type: COMPARATOR
Intervention: No treatment (period C)
Number of subjects: 111
Study: 3527853

Group type: EXPERIMENTAL
Intervention: End-to-side portacaval shunt (PCS)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Distal splenorenal shunt (DSRS)
Number of subjects: 54
Study: 29979913

Group type: EXPERIMENTAL
Intervention: Why-Quit messages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: How-To-Quit messages
Number of subjects: 0
Study: 26710753

Group type: EXPERIMENTAL
Intervention: Digital Brush with chlorhexidine 0.12%
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sterile gauze soaked in water (Control)
Number of subjects: 56
Study: 24456049

Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CsA)
Number of subjects: 356

Group type: COMPARATOR
Intervention: Tacrolimus
Number of subjects: 356
Study: 23913601

Group type: EXPERIMENTAL
Intervention: Selective infarct-related artery (sIRA) infusion of tirofiban (10 g/kg body weight) through aspiration catheter followed by 12 hours of intravenous infusion (0.1 g/kg/min)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Conventional intracoronary (IC) administration of tirofiban (10 g/kg body weight) through guiding catheter followed by 12 hours of intravenous infusion (0.1 g/kg/min)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: sIRA infusion of tirofiban
Number of subjects: 203

Group type: COMPARATOR
Intervention: Conventional IC administration of tirofiban
Number of subjects: 203
Study: 20159127

Group type: EXPERIMENTAL
Intervention: Timed Up & Go (TUG)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: SMAF-mobility
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: SMAF-ADL
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: SMAF-IADL
Number of subjects: 237
Study: 18436152

Group type: EXPERIMENTAL
Intervention: IV/IA (0.6 mg/kg IV ≤ 60 mg, followed by 0.3 mg/kg IA ≤ 30 mg)
Number of subjects: 1057

Group type: COMPARATOR
Intervention: IA therapy
Number of subjects: 1057

Group type: EXPERIMENTAL
Intervention: IV/IA
Number of subjects: 1057
Study: 16401336

Group type: EXPERIMENTAL
Intervention: FITT framework applied to nursing documentation system adoption
Number of subjects: 0
Study: 14714839

Group type: EXPERIMENTAL
Intervention: Mandibular conventional dentures
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Implant-supported overdentures
Number of subjects: 58
Study: 10697342

Group type: EXPERIMENTAL
Intervention: Buckley's Formocresol (F)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Calcium Hydroxide (C)
Number of subjects: 52
Study: 8713772

Group type: EXPERIMENTAL
Intervention: VIDAS D‐dimer ELISA, cut-off level of 500 ng/ml
Number of subjects: 195
Study: 1439288

Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 23
Study: 2986932

Group type: EXPERIMENTAL
Intervention: etomidate
Number of subjects: 30

Group type: COMPARATOR
Intervention: methohexital
Number of subjects: 30

Group type: COMPARATOR
Intervention: midazolam
Number of subjects: 30
Study: 30206824

Group type: EXPERIMENTAL
Intervention: Topical 0.25% finasteride combined with topical 3% minoxidil
Number of subjects: 30

Group type: COMPARATOR
Intervention: Topical 3% minoxidil solution as monotherapy
Number of subjects: 30
Study: 30371169

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training for 12 weeks
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training with lipopolysaccharide 0.1 ng/mL
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training with lipopolysaccharide 1.0 ng/mL
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 119

Group type: COMPARATOR
Intervention: Wait list control condition
Number of subjects: 119
Study: 27423256

Group type: EXPERIMENTAL
Intervention: TAK-063 (PDE10A inhibitor)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Baseline PET
Number of subjects: 12
Study: 25483462

Group type: EXPERIMENTAL
Intervention: GC FLU Prefilled Syringe
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: GC FLU Injection
Number of subjects: 1023
Study: 22218277

Group type: EXPERIMENTAL
Intervention: 30-second video with qualitative description
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: 30-second video with relative risk
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: 30-second video with absolute risk
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: 30-second video with absolute event-free survival
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: 30-second video with annualized absolute risk
Number of subjects: 409
Study: 19629583

Group type: EXPERIMENTAL
Intervention: Immune-enhanced diet (ID) group, n = 30
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional diet (CD) group, n = 30
Number of subjects: 60
Study: 17613965

Group type: EXPERIMENTAL
Intervention: Gamma-hydroxybutyrate (GHB) 50 mg/kg bodyweight, q.i.d.
Number of subjects: 42

Group type: COMPARATOR
Intervention: Diazepam 0.5 mg/kg bodyweight, q.i.d.
Number of subjects: 42
Study: 15002017

Group type: EXPERIMENTAL
Intervention: Dorzolamide 2%
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Brinzolamide 1%
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 11355117

Group type: EXPERIMENTAL
Intervention: Amikacin plus piperacillin/tazobactam (n = 88)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Amikacin plus ceftazidime (n = 36)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Amikacin plus piperacillin/tazobactam
Number of subjects: 124

Group type: COMPARATOR
Intervention: Amikacin plus ceftazidime
Number of subjects: 124
Study: 9554427

Group type: EXPERIMENTAL
Intervention: Prolonged exposure (imaginal and live)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Cognitive restructuring alone
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Combined prolonged exposure and cognitive restructuring
Number of subjects: 87

Group type: COMPARATOR
Intervention: Relaxation without prolonged exposure or cognitive restructuring
Number of subjects: 87
Study: 8111604

Group type: EXPERIMENTAL
Intervention: Procaterol hydrochloride (10 micrograms/puff, 2 puffs)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Ipratropium bromide (20 micrograms/puff, 2 puffs)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Procaterol hydrochloride
Number of subjects: 8

Group type: COMPARATOR
Intervention: Ipratropium bromide
Number of subjects: 8
Study: 3182457

Group type: EXPERIMENTAL
Intervention: Ofloxacin 100 mg bd
Number of subjects: 61

Group type: COMPARATOR
Intervention: Ciprofloxacin 250 mg bd
Number of subjects: 61

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Adverse reactions
Number of subjects: 61
Study: 31194645

Group type: EXPERIMENTAL
Intervention: Direct distribution system (cross-docking arrangement)
Number of subjects: 439

Group type: COMPARATOR
Intervention: Traditional three-level drug distribution system
Number of subjects: 439
Study: 28645982

Group type: EXPERIMENTAL
Intervention: Nasal high-flow (nHF) therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (CPAP)
Number of subjects: 0
Study: 26553733

Group type: EXPERIMENTAL
Intervention: Intralesional Mycobacterium w (Mw) vaccine
Number of subjects: 66

Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 66
Study: 23904350

Group type: EXPERIMENTAL
Intervention: Facial emotion recognition task with speeded responses to happy or sad faces
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polarity-based account
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conceptual-metaphor account
Number of subjects: 0
Study: 22174039

Group type: EXPERIMENTAL
Intervention: Entecavir
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Telbivudine
Number of subjects: 195
Study: 19384242

Group type: EXPERIMENTAL
Intervention: Intracoronary nitroprusside
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Adenosine
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 18416221

Group type: EXPERIMENTAL
Intervention: Group 1 (autologous shed mediastinal blood)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Group 2 (control group)
Number of subjects: 90
Study: 15884752

Group type: EXPERIMENTAL
Intervention: ORS‐75
Number of subjects: 144

Group type: COMPARATOR
Intervention: ORS‐90
Number of subjects: 144
Study: 12074773

Group type: EXPERIMENTAL
Intervention: Functional electrostimulation (FES)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Lower urinary tract exercises (LUTE)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: LUTE + FES
Number of subjects: 68

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 68
Study: 9719721

Group type: EXPERIMENTAL
Intervention: Adduction group (20 patients)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Abduction group (20 patients)
Number of subjects: 40
Study: 9350490

Group type: EXPERIMENTAL
Intervention: Microsurgical bipolar dissection technique (MBCT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cold sharp dissection with ligation for securing hemostasis (CSDL)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 60
Study: 1937659

Group type: EXPERIMENTAL
Intervention: Bicycle exercise 3 times/wk (40 minutes at 60-70% maximum work capacity)
Number of subjects: 8
Study: 7096587

Group type: EXPERIMENTAL
Intervention: Training program lasting approximately 1 month designed to establish a systematic strategy of organizing complex visual material.
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (18 patients) re-examined after 1 month without intervention.
Number of subjects: 35
Study: 29948275

Group type: EXPERIMENTAL
Intervention: Filtek Supreme (FS) Ultra Universal
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Filtek Bulk (FB) Fill Flowable
Number of subjects: 22
Study: 28415979

Group type: EXPERIMENTAL
Intervention: Behavioral Activation Treatment for Cardiac Smokers (BAT-CS)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard of Care (SC)
Number of subjects: 59
Study: 26476609

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon (PCB) angioplasty
Number of subjects: 110

Group type: COMPARATOR
Intervention: Plain old balloon angioplasty (POBA)
Number of subjects: 110
Study: 25038861

Group type: EXPERIMENTAL
Intervention: DTI assessment using respiratory-triggered coronal EPI sequence (TR, 1400 ms; TE, 76 ms; diffusion direction, 6; NEX, 4; b values, 0 and 600 s/mm2; slices thickness, 6 mm)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 75
Study: 23954520

Group type: EXPERIMENTAL
Intervention: Intramuscular magnesium sulphate (IMMG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 22152168

Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate (LC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sevelamer hydrochloride (SH)
Number of subjects: 0
Study: 19565120

Group type: EXPERIMENTAL
Intervention: Topical benzyl benzoate (BB2 group) - two applications of 12.5% BB over 24 hours
Number of subjects: 181

Group type: COMPARATOR
Intervention: Topical benzyl benzoate (BB1 group) - single application of 12.5% BB over 24 hours
Number of subjects: 181

Group type: COMPARATOR
Intervention: Oral ivermectin (IV group) - 150‐200 microg/kg
Number of subjects: 181
Study: 17098762

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 155

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 155
Study: 15293079

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 25

Group type: COMPARATOR
Intervention: Indinavir-containing HAART
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Pravastatin and Fluvastatin
Number of subjects: 25
Study: 11169174

Group type: EXPERIMENTAL
Intervention: Pulsed monochromatic infrared (956 nm) and red (637 nm) light therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard ulcer therapy (Control)
Number of subjects: 0
Study: 10450730

Group type: EXPERIMENTAL
Intervention: Subtotal Gastrectomy (SG)
Number of subjects: 618

Group type: COMPARATOR
Intervention: Total Gastrectomy (TG)
Number of subjects: 618
Study: 7925339

Group type: EXPERIMENTAL
Intervention: 26 gauge Yale needle
Number of subjects: 100

Group type: COMPARATOR
Intervention: 24 gauge Sprotte needle
Number of subjects: 100
Study: 2928151

Group type: EXPERIMENTAL
Intervention: Inguinal temperature measurement
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Axillary temperature measurement
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Rectal temperature measurement
Number of subjects: 120